“CFI-400945 in Patients With Advanced/Metastatic Breast Cancer”
The standard or usual treatment for this disease is to undergo chemotherapy to slow the spread of the disease and relieve some symptoms of cancer. Patients will have already had at least one chemotherapy treatment for their disease at this stage.
Drug - CFI-400945
Cycle 1 dose assigned at enrollment, cycle1: day 1-7, 15-21; 28 day cycle. Cycle 2 onwards (28 days duration):
A Phase II Study of CFI-400945 in Patients With Advanced/Metastatic Breast Cancer